Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

18.30
+0.67003.80%
Pre-market: 18.500.2000+1.09%07:17 EDT
Volume:1.25M
Turnover:22.80M
Market Cap:2.53B
PE:-16.10
High:18.43
Open:17.87
Low:17.75
Close:17.63
Loading ...
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2024

Major Issues Report

Form 8-K - Current report
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities